Lingzhi Wang
- Topics
- Cancer-related molecular mechanisms research (5 papers)Peptidase Inhibition and Analysis (3 papers)RNA modifications and cancer (3 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Lingzhi Wang
24 papers receiving 704 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Molecular Biology 410
- Cancer Research 257
- Oncology 185
- Immunology 171
- Pulmonary and Respiratory Medicine 111
Countries citing papers authored by Lingzhi Wang
This map shows the geographic impact of Lingzhi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingzhi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingzhi Wang more than expected).
Fields of papers citing papers by Lingzhi Wang
This network shows the impact of papers produced by Lingzhi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingzhi Wang. The network helps show where Lingzhi Wang may publish in the future.
Co-authorship network of co-authors of Lingzhi Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Lingzhi Wang. A scholar is included among the top collaborators of Lingzhi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingzhi Wang. Lingzhi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 23 | |
| 7 | 11 | |
| 8 | 40 | |
| 9 | 15 | |
| 10 | 25 | |
| 11 | 15 | |
| 12 | 23 | |
| 13 | 24 | |
| 14 | 7 | |
| 15 | 30 | |
| 16 | 22 | |
| 17 | 304 | |
| 18 | 1 | |
| 19 | 28 | |
| 20 | 1 |
About Lingzhi Wang
Lingzhi Wang is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 27 papers that have together received 710 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Peptidase Inhibition and Analysis (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (257 citations), Immunology (171 citations) and Oncology (185 citations). Lingzhi Wang has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Zhihao Wu, Weihong Cao, Zhengbiao Zhu, Mengmeng Yang, Yiqun Zhang, Hui Yang, Huijun Wei, Jie Feng, Yanling Lin and Zhian Chen. Their work appears in journals such as Advanced Materials, Nature Communications and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.